Patients with glaucoma treated with iDose TR experienced sustained IOP reductions, according to a press release from ...

Glaukos GKOS recently announced positive data from a new 36-month follow-up analysis of its two Phase 3 pivotal clinical ...

Glaucoma is a chronic eye disease caused by fluid building up in front of the eye. This can result in pressure and damage to the optic nerve. Treatment for glaucoma includes medications such as ...

Extended preoperative use of topical glaucoma medications with preservatives may negatively affect long-term trabeculectomy ...

The rates at which ganglion cell-inner plexiform layer (GCIPL) and retinal nerve fiber layer (RNFL) thin in the eyes was ...

Glaucoma has been called ‘the thief of sight’ because it sneaks up on people. They don’t realize they have it,” said Dr. Anna ...

Patients with osteoporosis who took bisphosphonates, especially risedronate, were at a higher risk of developing acute angle ...

Glaucoma is actually a group of eye diseases that damage the optic nerve in the back of the eye and cause vision loss and ...

Results Cases were more likely to have coronary artery disease, chronic obstructive pulmonary ... Recently, it has been suggested that open-angle glaucoma (OAG) is associated with higher incidence ...

NYSE:GKOS) Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform ...